Buckner, Jane H. https://orcid.org/0000-0002-9005-1885
Article History
Accepted: 26 November 2024
First Online: 16 December 2024
Competing interests
: J.H.B. is a scientific co-founder and scientific advisory board member of GentiBio, consultant for Bristol Myers Squibb and Hotspot Therapeutics, and has past and current research projects sponsored by GentiBio, Amgen, Bristol Myers Squibb, Janssen, Novo Nordisk and Pfizer. She is a member of the Type 1 Diabetes TrialNet study group, a partner of the Allen Institute for Immunology, and a member of the scientific advisory boards for the La Jolla Institute for Allergy and Immunology and BMS Immunology.